You are Here
Great Challenges, Big Dreams

Great Challenges, Big Dreams

1 min read
A month chock-full of fireworks and milestones closed on a somewhat muted note, as equities came off records despite more good news on Moderna's COVID-19 vaccine, which is apparently 100% effective at preventing severe disease. The company indicated it would immediately request Emergency Use Authorization from the FDA and conditional approval from Europe. The shares soared. The stock's up sevenfold in 2020, which I guess is what happens when you successfully develop a vaccine against a virus th
Every story you need, no story you don't. Get the best daily market and macroeconomic commentary anywhere for less than $7 per month. Subscribe or log in to continue.

Speak your mind

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Month’s Best

Monthly Letter: That’s Great, It Starts With An Earthquake

1 min read
[Editor's note: Early next month, a new tier of subscription will be available to interested…

Monthly Letter: Addiction Liability And The Roaring Twenties

1 min read
[Editor's note: Starting in February 2023, I'll be offering a new subscription tier that includes,…

The Tragedy Of America’s $3.5 Trillion In ‘Extra’ Savings

1 min read
Back in June, I told readers the "sad, sad story" of $3 trillion in pandemic…

The Dawn Of The Great Immoderation

1 min read
It's a heretical notion, but I'm compelled to repeat it at regular intervals: It's the…

Burning City On A Hill

1 min read
I've come to despise politics, which is unfortunate because I was raised around political scientists,…

Jeffrey Sachs And The Nord Stream: A Counter-Narrative Case Study

1 min read
I've long described my raison d'être in terms of the intersection between geopolitics and finance.…
Order Now

NEWSROOM crewneck & prints